Malawi – Patrick Chakwana, 50, has lived with HIV since 1999, when there was no effective treatment and the message to those diagnosed was blunt: "Aids kills". Today, as Malawi becomes one of the latest African countries to roll out lenacapavir, a twice-yearly injectable drug that prevents HIV infection, Chakwana's reaction is one of hope, tempered by caution.
"I've faced stigma from the community and workplaces," the soft-spoken man told RFI, sitting at a desk in a small office off the road connecting the tea-growing district of Thyolo with the commercial city of Blantyre.
